Alzheimer's disease traits in Parkinson's disease without α‐synuclein seeding
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Bárbara Fernandes Gomes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölnd…. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein, Alzheimer Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Medical Research Council, Erling-Persson Foundation, Hjärnfonden.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION The α‐synuclein (αSyn) seed amplification assay (αSyn‐SAA) is an accurate tool to detect αSyn seeds in patients with Parkinson's disease (PD). However, a minority of clinically diagnosed PD patients are negative for αSyn. METHODS The αSyn‐SAA was performed in cerebrospinal fluid (CSF) of individuals with PD ( n = 93), multiple system atrophy (MSA, n = 26), progressive supranuclear palsy (PSP, n = 18), corticobasal syndrome ( n = 3), and healthy controls ( n = 29). RESULTS The αSyn‐SAA detected αSyn in 90% of PD and 81% of MSA patients, while exhibiting high specificity (97%). SAA– PD patients had a distinct phenotype compared to SAA+ PD, including a marked postural instability/gait disorder ( P = 0.002), impaired episodic memory, and lower CSF amyloid beta 42 ( P = 0.03). SAA+ PSP also displayed distinctive traits. DISCUSSION A negative αSyn‐SAA in PD is associated with a distinct phenotype and pathological findings suggesting that these patients may have a motor subtype of Alzheimer's disease. This could influence future clinical trials. Highlights The α‐synuclein seed amplification assay (αSyn‐SAA) is a robust assay. αSyn‐SAA–negative Parkinson's disease shows a distinct motor–cognitive phenotype. Autopsy showed Alzheimer's disease (AD) pathology in parkinsonian diseases. AD stands as a major clinical confounder for the diagnosis of movement disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
- R&D Unit, Amprion Inc., San Diego, California, USA.
- Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
- Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.
- Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated…
ORCID-Profile: Bárbara Fernandes Gomes
Förderung
- Swedish Medical Research Council
- Erling-Persson Foundation
- Hjärnfonden
- Swedish Parkinson Foundation
- Parkinson Research Foundation
- Kempe Foundation
- Swedish PD Association
- European Research Council
Zitieren
APA
Fernandes Gomes, B., Farris, C. M., Ma, Y., Concha-Marambio, L., Nilsson, J., Forsberg, K., Lebovitz, R., Andreasson, U., Blennow, K., Zetterberg, H., & Bäckström, D. (2025). Alzheimer's disease traits in Parkinson's disease without α‐synuclein seeding. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70284
Vancouver
Fernandes Gomes B, Farris CM, Ma Y, Concha-Marambio L, Nilsson J, Forsberg K, et al. Alzheimer's disease traits in Parkinson's disease without α‐synuclein seeding. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70284
BibTeX
@article{FernandesGomes2025,
author = {Fernandes Gomes, Bárbara and Farris, Carly M and Ma, Yihua and Concha-Marambio, Luis and Nilsson, Johanna and Forsberg, Karin and Lebovitz, Russ and Andreasson, Ulf and Blennow, Kaj and Zetterberg, Henrik and Bäckström, David},
title = {Alzheimer's disease traits in Parkinson's disease without α‐synuclein seeding},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70284}
}
EUVIMED